EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression

Rodolfo Myronn de Melo Rodrigues

Psychedelics · 2024

DOI: 10.61373/pp024c.0022 ↗

At a glance

Journal article in Psychedelics, 2024. Written by Rodolfo Myronn de Melo Rodrigues. 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Depression is a global public health challenge that represents the world's largest cause of disability, especially in the context of traditional treatments. One potential solution being explored is psilocybin assisted psychotherapy (PAP) which shows promise for treating depression. A recent study by Rosenblat et al. explores the use of psilocybin in clinical mental care with promising results (1).

Cite

APA

Rodrigues, R. M. D. M. (2024). Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression. Psychedelics. https://doi.org/10.61373/pp024c.0022

Vancouver

Rodrigues RMDM. Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression. Psychedelics. 2024. doi:10.61373/pp024c.0022

BibTeX
@article{Rodrigues2024,
  author = {Rodrigues, Rodolfo Myronn de Melo},
  title = {Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression},
  journal = {Psychedelics},
  year = {2024},
  doi = {10.61373/pp024c.0022}
}
Start for free →